Supply chain resiliency | COVID-19: What now. What next.

Series overview

Interactive conversations in KPMG LLP's series What now. What next.

Let’s talk. As the world heads into uncharted territory, business leaders are navigating the impacts of COVID-19. Now is the time to discuss the new reality.

With an agenda shaped by your input, we're meeting often to address the business-critical challenges brought on by this pandemic. KPMG is actively connecting with the market to share leading perspectives from hundreds of clients around the world. Join us for this series as we talk through the most pressing issues and solutions we’ve heard from executives, governments and other regulators.

The topic discussed May 22 was supply chain risk.

Supply chain resiliency: The best ecosystems win

In the era of COVID-19, organizations are monitoring their liquidity and the liquidity of their suppliers as frequently as on a daily basis. The pressure on the supply chain is at a breaking point. The competitively-advantaged are organizations with a strong ecosystem of suppliers that are able to sustain supply and have access to capital. In this interactive webcast discussion, we will share ways to anticipate supply chain risk, strategies to respond to disruptions, and the ups and downs of supply chain liquidity. 

Access the recording of this discussion

Webcast summary: May 22, 2020 KPMG What now. What next.
Key takeaways from our panel discussion on Supply chain resiliency: The best ecosystems win

Panelists for the May 22 discussion

Kelli Brooks

Kelli Brooks

Principal, National Life Sciences Consulting Leader, KPMG US

+1 213-533-3389
Kerim Ozbilge

Kerim Ozbilge

Advisory Managing Director, Supply Chain & Operations, KPMG US

+1 312-665-2337
Amanda Rigby

Amanda Rigby

Forensic Services Leader, KPMG US

+1 312-665-1953
Mary J. Rollman

Mary J. Rollman

Principal, Advisor/Supply Chain Strategy and Life Sciences Lead, KPMG US

+1 312-618-9863